Admission Date:  [**2159-1-15**]              Discharge Date:   [**2159-1-19**]   Service: MEDICINE  Allergies: Latex / Lipitor  Attending:[**First Name3 (LF) 613**] Chief Complaint: found unresponsive, not moving R  Major Surgical or Invasive Procedure: none   History of Present Illness: 82 y/o f with h/o CAD, CHF EF 20%, known LV thrombus, pacer, breast cancer was found in her home by a neighbor at a senior living community to be awake but unresponsive and not moving her R side.
She was taken to [**Location (un) 620**] where a head CT revealed a L basal ganglia CVA.
At [**Location (un) 620**] ED: She was given ASA 300 mg, lasix for some evidence of fluid overload.
She was transferred to [**Hospital1 18**] for possible cath and to have NSG backup.
At [**Hospital1 18**] ED: Her HR was 75 paced, BP 155/76, R18, sat 100% RA, EKG was paced at 75 without changes.
CXR revealed CHF and LLL infiltrate with WBC 13.7.
Currently nods to questions and is not having any pain, or other complaints.
Past Medical History: CHF with EF 20% large LV thrombus- refused anticoagulation [**11-13**] s/p pacemaker HTN breast ca s/p matectomy Lymphoma s/p hernia repair DNR/I  Social History: Lives alone in Senior Center  Family History: n-c  Physical Exam: T 98.4 P95 BP 133/56  R10 SAt 93%RA gen: lethargic, in no distress, nods to questions HEENT: dry MM CV: RRR pulm: clear, no wheezes, slow resp rate abd: soft NT/ND, +BS ext: no edema neuro: no strength on RUE/RLE, 3/5 strength LUE/LLE   Pertinent Results: [**2159-1-15**] 11:31PM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.020 [**2159-1-15**] 11:31PM URINE  BLOOD-MOD NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2159-1-15**] 11:31PM URINE  RBC-12* WBC-0 BACTERIA-NONE YEAST-NONE EPI-0 [**2159-1-15**] 06:53PM   GLUCOSE-105 UREA N-29* CREAT-1.0 SODIUM-139 POTASSIUM-3.8 CHLORIDE-105 TOTAL CO2-23 ANION GAP-15 [**2159-1-15**] 06:53PM   CK-MB-73* cTropnT-2.01* [**2159-1-15**] 06:53PM   WBC-16.2* RBC-3.77* HGB-11.2* HCT-33.6* MCV-89 MCH-29.7 MCHC-33.4 RDW-15.2 [**2159-1-15**] 06:53PM   PLT COUNT-204 [**2159-1-15**] 06:53PM   PTT-40.9* [**2159-1-15**] 11:31AM   LACTATE-1.4 [**2159-1-15**] 11:20AM   GLUCOSE-126* UREA N-29* CREAT-1.0 SODIUM-141 POTASSIUM-4.0 CHLORIDE-104 TOTAL CO2-24 ANION GAP-17 [**2159-1-15**] 11:20AM   CK(CPK)-476* [**2159-1-15**] 11:20AM   CK-MB-78* MB INDX-16.4* cTropnT-1.20* [**2159-1-15**] 11:20AM   WBC-13.7* RBC-3.92* HGB-12.0 HCT-34.9* MCV-89 MCH-30.5 MCHC-34.3 RDW-15.0 [**2159-1-15**] 11:20AM   NEUTS-71* BANDS-0 LYMPHS-26 MONOS-2 EOS-1 BASOS-0 ATYPS-0 METAS-0 MYELOS-0 [**2159-1-15**] 11:20AM   HYPOCHROM-1+ ANISOCYT-1+ POIKILOCY-OCCASIONAL MACROCYT-OCCASIONAL MICROCYT-NORMAL POLYCHROM-NORMAL OVALOCYT-OCCASIONAL SCHISTOCY-OCCASIONAL [**2159-1-15**] 11:20AM   PT-13.1 PTT-22.0 INR(PT)-1.1 .
Head CT: CONCLUSION:  No significant change in appearance of suspected infarction involving a substantial portion of the inferior division of the left middle cerebral artery.
Brief Hospital Course: 82 [**Last Name (un) **] with h/o CAD, CHF EF 20%, known LV thrombus not on anticoagulation, and breast cancer presented with L basal ganglia CVA and acute non-ST elevation MI.
Patient was a not a candidate for thrombolysis.
Neurology and physical therapy were involved and felt there was minimal rehab potential as patient was minimally responsive to external stimuli.
morphine boluses were given to control pain and respiratory distress.
# Pneumonia: Patient presented with LLL infiltrate and leukocytosis.
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day) as needed for constipation.
Disp:*qs mL* Refills:*0*   Discharge Disposition: Extended Care  Facility: Hospice of [**Location (un) 1121**] [**Hospital1 656**] Family Residence  Discharge Diagnosis: Primary: basal ganglia stroke NSTEMI .
Secondary: congestive heart failure breast cancer s/p mastectomy hypertension lymphoma   Discharge Condition: stable, comfortable   Discharge Instructions: Please continue intensive comfort measures with prn morphine, roxicet; may use morphine gtt as needed  Followup Instructions: per Hospice Care                                [**First Name5 (NamePattern1) **] [**Last Name (NamePattern1) **] MD [**MD Number(2) 617**]
